Immuneering CorporationIMRXNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Latest
17.42%
↑ 131% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthAccelerating
Average
-55.54%
Historical baseline
PeriodValue
202517.42%
2024-11.71%
2023-9.96%
2022-45.07%
2021-110.65%
2020-228.80%
20190.00%